{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2012"],"condition":["Neoplasms"],"disease":["Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2509326"],"location":["South Korea"],"study_start_month":["9"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"The role of Gut ecosystem in obesity and colorectal patients","description":"Interventions: Dietary Supplement : Intervention group\nBrand name: Lacidofil \nIngredient: contained L. rhamnosus R0011, L. acidophilus R0052 bacterial culture (2×109 colony-forming units), maltodextrin, magnesium stearate\ndose: 1 capsule twice a day right after the meal\nplacebo\nreceived placebo pills composed of maltodextrin, magnesium stearate, and ascorbic acid. The placebo was comparable in texture, taste, and color to the probiotics.\ndose: 1 capsule twice a day right after the meal\nPrimary outcome(s): Irritable bowel symptom\nPrimary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Outcome Accessor, Allocation : RCT","dates":{"creation":"2012-09-15"},"accession":"2509326","cross_references":{"Clinical Research Information Service":["KCT0001053"]}}